You are here

Biphasic Catalytic Asymmetric Hydrogenation Process

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43GM076754-01
Agency Tracking Number: GM076754
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2006-2
Timeline
Solicitation Year: 2006
Award Year: 2006
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
TDA RESEARCH, INC. 12345 W 52ND AVE
WHEAT RIDGE, CO 80033
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 STEVEN DIETZ
 (303) 940-2312
 HTTP://WWW.TDA.COM
Business Contact
 JOHN WRIGHT
Phone: (303) 940-2300
Email: JDWRIGHT@TDA.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): A major change in pharmaceutical manufacturing is the current shift from batch to continuous processing. Manufacturing costs account for 36% of the industries costs and continuous processing can reduce operating expenses by at least 90% and capital expenses by at least 50%. The FDA and industry are working to bring continuous processing to pharmaceutical manufacturing. The use of enantioselectivity catalysts is another means to reduce costs. Homogeneous catalysts are able to produce chiral drugs and intermediates with very high enantioselectivity. Unfortunately, these processes suffer problems, it is very difficult to remove the expensive catalyst from the reaction mixture and the reactions used to make active ingredients in the pharmaceutical industry have typically been carried out as batch reactions. One of the most important classes of homogeneous chiral reactions is asymmetric hydrogenation, which is used to make a variety of active ingredients, including Vitamin E, Carbapenem, S-Oxafloxazin and Aspartame. The goal of this proposal is to develop an asymmetric hydrogenation process that allows the continual feed, reaction, separation and reuse of a chiral catalyst resulting in dramatic saving in process costs.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government